Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 71.66 USD 1.24% Market Closed
Market Cap: 28.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+10%
Revenue
Forecast
+7%
Operating Income
Forecast
+9%
Net Income
Forecast
+15%

Wall Street
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 103.23 USD with a low forecast of 80.8 USD and a high forecast of 126 USD.

DXCM Lowest Forecast
Wall Street Target
80.8 USD
13% Upside
DXCM Average Forecast
Wall Street Target
103.23 USD
44% Upside
DXCM Highest Forecast
Wall Street Target
126 USD
76% Upside
Lowest
Price Target
80.8 USD
13% Upside
Average
Price Target
103.23 USD
44% Upside
Highest
Price Target
126 USD
76% Upside
Dexcom Inc Competitors:
Price Targets
7817
Paramount Bed Holdings Co Ltd
16% Upside
P
FNA
Paragon 28 Inc
9% Upside
GMED
Globus Medical Inc
37% Upside
INMD
Inmode Ltd
33% Upside
7817
Paramount Bed Holdings Co Ltd
16% Upside
P
FNA
Paragon 28 Inc
9% Upside
GMED
Globus Medical Inc
37% Upside
INMD
Inmode Ltd
33% Upside
V
100120
Vieworks Co Ltd
30% Upside
6823
Rion Co Ltd
43% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
43% Upside
MASI
Masimo Corp
22% Upside

Revenue
Forecast

Revenue Estimate
Dexcom Inc

For the last 8 years the compound annual growth rate for Dexcom Inc's revenue is 28%. The projected CAGR for the next 3 years is 16%.

28%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dexcom Inc

The compound annual growth rate of Dexcom Inc's operating income for the next 3 years is 33%.

N/A
Past Growth
33%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dexcom Inc

The compound annual growth rate of Dexcom Inc's net income for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall Street Estimates
DXCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXCM's stock price target?
Price Target
103.23 USD

According to Wall Street analysts, the average 1-year price target for DXCM is 103.23 USD with a low forecast of 80.8 USD and a high forecast of 126 USD.

What is Dexcom Inc's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Dexcom Inc's revenue is 28%. The projected CAGR for the next 3 years is 16%.

What is Dexcom Inc's Operating Income forecast?
Projected CAGR
33%

The compound annual growth rate of Dexcom Inc's operating income for the next 3 years is 33%.

What is Dexcom Inc's Net Income forecast?
Projected CAGR
28%

The compound annual growth rate of Dexcom Inc's net income for the next 3 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.